Table 2.
Summary of the reported CRISPR-based diagnostics with LOD and CRISPR reaction time available.
| Pathogen | Target | Effector | Readout System | Amplification | Amplification time (min) | CRISPR reaction time (min) | LOD (aM) | FOM (aM.min) | Ref. |
|---|---|---|---|---|---|---|---|---|---|
| Ensemble without amplification | |||||||||
|
| |||||||||
| African Swine Fever | DNA | LbCas12a | Fluorescence | None | None | 480 | 1e6 | 4.8e8 | 110 |
| African Swine Fever | DNA | LbCas12a | Fluorescence | None | None | 1440 | 1e5 | 1.4e8 | 110 |
| Pseudorabies virus | DNA | LbCas12a | Fluorescence | None | None | 15 | 1e8 | 1.5e9 | 8 |
| Liver cancer | DNA | LbCas12a | Colorimetric | None | None | 60 | 2e8 | 1.2e10 | 15 |
| HPV | RNA | LbCas12a | Electrochemical | None | None | 60 | 3e7 | 1.8e9 | 105 |
| Zika virus | RNA | LwCas13a | Fluorescence | None | None | 60 | 5e5 | 3e7 | 9 |
| SARS-CoV-2 | RNA | LbuCas13a | Fluorescence | None | None | 120 | 1.6e4 | 1.9e6 | 69 |
| Synthesized target | RNA | LbuCas13a | Fluorescence | None | None | 120 | 1e6 | 1.2e8 | 104 |
| Synthesized target | RNA | LbuCas13a | Fluorescence | None | None | 20 | 3.7e9 | 7.4e10 | 83 |
| HPV | DNA | LbCas12a | Electrochemical | None | None | 60 | 5e7 | 3e9 | 20 |
| miR-19b and miR-20a | mRNA | LwaCas13a | Electrochemical | None | None | 15 | 1e7 | 1.5e8 | 14 |
| DENV-4 | DNA | AsCas12a | Electrochemical | None | None | 120 | 1e5 | 1.2e7 | 94 |
| BRCA-1 | DNA | AsCas12a | Fluorescence | None | None | 30 | 1e3 | 3e4 | 93 |
| HPV | DNA | LbCas12a | Fluorescence | None | None | 60 | 1e4 | 6e5 | 92 |
| Bacillus anthracis gene | DNA | LbCas12a | Fluorescence | None | None | 15 | 1e7 | 1.5e8 | 91 |
| Synthesized target | DNA | LbCas12a |
Fluorescence | None | None | 60 | 1e5 | 6e6 | 90 |
|
| |||||||||
| Ensemble with amplification | |||||||||
|
| |||||||||
| Citrus greening disease | DNA | LbCas12a | Fluorescence | LAMP | 40 | 5 | 16.6 | 83 | 112 |
| African Swine Fever (ASF) | DNA | LbCas12a | Fluorescence | LAMP | 40 | 20 | 3.6 | 72 | 111 |
| HPV | DNA | LbCas12a | Fluorescence | RPA | 15 | 60 | 16.6 | 1e3 | 109 |
| ASF | DNA | LbCas12a | Fluorescence | RPA | 30 | 60 | 10 | 600 | 108 |
| SARS-CoV-2 | RNA | LbCas12a | Fluorescence | RPA | 30 | 30 | 16.6 | 498 | 116 |
| HPV | DNA | LbCas12a | Fluorescence | RPA | 10 | 60 | 10 | 600 | 52 |
| Pseudorabies virus | DNA | LbCas12a | Fluorescence | PCR | 45 | 15 | 10 | 150 | 8 |
| SARS-CoV-2 | RNA | LbCas12a | Fluorescence | RPA (one pot) | None | 40 | 80.3 | 3.2e3 | 25 |
| P.aeruginosa | DNA | LbCas12a | Colorimetric | LAMP | 15 | 30 | 3.4 | 102 | 107 |
| HPV | DNA | LbCas12a | Colorimetric | PCR | 50 | 30 | 240 | 7.2e3 | 106 |
| Ebola virus | RNA | LbCas12a | Fluorescence | RPA | 40 | 240 | 10 | 2.4e3 | 46 |
| Synthesized target | RNA | AacCas12b | Fluorescence | LAMP | 30 | 30 | 10 | 300 | 16 |
| SARS-CoV-2 | RNA | AacCas12b | Fluorescence | RAA | 30 | 30 | 16.6 | 498 | 26 |
| Zika virus | RNA | LwCas13a | Fluorescence | RPA | 120 | 60 | 2 | 120 | 9 |
| Zika Virus | RNA | LbuCas13a | Fluorescence | RPA | 20 | 60 | 6 | 360 | 19 |
| Cytomegalovirus | DNA | LwCas13a | Fluorescence | RPA | 50 | 180 | 0.6 | 108 | 103 |
| White Spot Syndrome | RNA | Cas13a | Colorimetric | RPA | 40 | 180 | 1.6 | 288 | 102 |
| Various tumor cells | mRNA | LbuCas13a | Electrochemical | EXPAR | 30 | 30 | 1e3 | 3e4 | 21 |
| SARS-CoV-2 | RNA | AsCas12a | Nanopore | PCR | 30 | 30 | 22.5 | 675 | 45 |
| SARS-CoV-2 | RNA | LbCas12a | Fluorescence | LAMP | 30 | 10 | 16.6 | 166 | 23 |
| SARS-CoV-2 | RNA | AsCas12a | Fluorescence | LAMP | 30 | 30 | 8.3 | 249 | 24 |
| SARS-CoV-2 | RNA | LwaCas13a | Fluorescence | RPA | 20 | 60 | 16.6 | 996 | 28 |
| SARS-CoV-2 | RNA | LbCas12a | Fluorescence | LAMP | 20 | 15 | 16.6 | 249 | 101 |
| HPV | DNA | AaCas12b | Fluorescence | RPA | 10 | 180 | 1 | 180 | 100 |
| SARS-CoV-2 | RNA | AapCas12b | Fluorescence | LAMP (one pot) | None | 60 | 3.3 | 198 | 48 |
| Different Viruses | RNA | LwaCas13a | Fluorescence | PCR or RPA | 20 | 180 | 0.9 | 162 | 99 |
| SARS-CoV-2 | RNA | LbCas12a | Colorimetric | RPA | 30 | 20 | 8.3 | 166 | 98 |
| Listeria monocytogenes | DNA | LbCas12a | Electrochemical | RAA | 30 | 90 | 0.68 | 61.2 | 97 |
| SARS-CoV-2 | RNA | LbCas12a | Fluorescence | RPA | 30 | 10 | 16.6 | 166 | 96 |
| SARS-CoV-2 | RNA | LwaCas13a | Fluorescence | PCR | 22 | 30 | 332 | 1e4 | 27 |
| SARS-CoV-2 | RNA | LbCas12a | Colorimetric | RPA | 20 | 60 | 1.6 | 96 | 95 |
| SARS-CoV-2 | RNA | LbCas12a | Fluorescence | RPA | 15 | 25 | 83 | 2.1e3 | 89 |
| Staphylococcus aureus | DNA | LbCas12a | Colorimetric | RAA | 20 | 30 | 1 | 30 | 88 |
| SARS-CoV-2 | RNA | LbCas12a | Fluorescence | RPA (one pot) | None | 60 | 2 | 120 | 113 |
| SARS-CoV-2 | RNA | LbCas12a |
Fluorescence | LAMP | 10 | 25 | 6.5 | 162.5 | 114 |
| SARS-CoV-2 | RNA | LbCas12a |
Fluorescence | LAMP | 40 | 10 | 26 | 260 | 115 |
|
| |||||||||
| Ensemble using multiple crRNA | |||||||||
|
| |||||||||
| SARS-CoV-2 | RNA | LbuCas13a | Fluorescence | None | None | 120 | 166 | 2e4 | 69 |
| Synthesized target | DNA | LbCas12a | Fluorescence | None | None | 30 | 310 | 9.3e3 | 117 |
|
| |||||||||
| Digital without amplification | |||||||||
|
| |||||||||
| ASF | DNA | LbCas12a | Fluorescence | None | None | 60 | 30 | 1.8e3 | 65 |
| SARS-CoV-2 | RNA | LbuCas13a | Fluorescence | None | None | 60 | 10 | 600 | 74 |
| SARS-CoV-2 | RNA | LbuCas13a | Fluorescence | None | None | 15 | 8.3 | 124.5 | 72 |
|
| |||||||||
| Digital with amplification | |||||||||
|
| |||||||||
| SARS-CoV-2 | RNA | LbCas12a | Fluorescence | RPA (one pot) | None | 60 | 1.5 | 90 | 86 |
| SARS-CoV-2 | RNA | Cas12a | Fluorescence | RPA (one pot) | None | 60 | 1.6 | 96 | 85 |
| SARS-CoV-2 | RNA | LbCas12a | Fluorescence | DAMP (one pot) | None | 50 | 8.3 | 415 | 39 |
| SARS-CoV-2 | RNA | AapCas12b | Fluorescence | LAMP (one pot) | None | 120 | 23 | 2.7e3 | 118 |
|
| |||||||||
| Digital using multiple crRNA | |||||||||
|
| |||||||||
| SARS-CoV-2 | RNA | LbuCas13a | Fluorescence | None | None | 15 | 1.6 | 24 | 72 |